专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5151435A Angiotensin II antagonists incorporating an indole or dihydroindole 失效
标题翻译： ANGIOTENSIN II ANTAGONISTS INCORPORATING IN INDOLE or DIHYDROINDOLE
公开(公告)号：US5151435A
公开(公告)日：1992-09-29
申请号：US681793
申请日：1991-04-08
申请人： Scott Bagley , William J. Greenlee , Daljit S. Dhanoa , Arthur A. Patchett
发明人： Scott Bagley , William J. Greenlee , Daljit S. Dhanoa , Arthur A. Patchett
IPC分类号： A61K31/415 , A61K31/495 , A61K31/505 , A61K31/52 , A61P9/00 , A61P9/12 , A61P43/00 , C07D403/06 , C07D403/14 , C07D471/04 , C07D473/00 , C07D473/40 , C07D487/04
CPC分类号： C07D473/00 , C07D403/06 , C07D403/14 , C07D471/04
摘要： There are disclosed substituted indoles and dihydroindoles of Formula I which are useful as angiotensin II antagonists. ##STR1##

2. 发明申请

US20160358284A1 COMPUTERIZED SYSTEM AND METHOD FOR CODING MEDICAL RECORDS 审中-公开
标题翻译：用于编码医疗记录的计算机系统和方法
公开(公告)号：US20160358284A1
公开(公告)日：2016-12-08
申请号：US13276741
申请日：2011-10-19
申请人： Scott Bagley
发明人： Scott Bagley
IPC分类号： G06Q50/24
CPC分类号： G06Q50/22
摘要： A computerized system and method for medical record coding is disclosed. The computerized system and method facilitates pre-screening of medical records and analyzes medical record data to identify potential coding errors. When potential coding errors are identified in a record, the suspect record is forwarded to a certified medical coder to confirm the presence or absence of the error. In an example embodiment, synonyms likely to be found in medical records are associated with standardized medical terms and codes and stored in a database. The computerized system and method searches electronic records using the synonyms. If a synonym is present in a record, the system identifies an appropriate code for the associated medical condition confirms that the appropriate medical code is associated with the record. If the code is not found, appropriate action is taken to correct the coding error. Multiple levels of review may be applied to each record.
摘要翻译：公开了一种用于医疗记录编码的计算机化系统和方法。计算机化系统和方法有助于对病历进行预筛选，并分析医疗记录数据以识别潜在的编码错误。当在记录中识别出潜在的编码错误时，将可疑记录转发给经认证的医疗编码器以确认是否存在错误。在一个示例性实施例中，可能在医疗记录中找到的同义词与标准化医学术语和代码相关联并存储在数据库中。计算机化系统和方法使用同义词搜索电子记录。如果记录中存在同义词，则系统识别相关医疗状况的适当代码，确认适当的医学代码与记录相关联。如果找不到代码，则采取适当的措施来纠正编码错误。可以对每个记录应用多个级别的审查。

3. 发明授权

US5175164A Angiotensin II antagonists incorporating a substituted indole or dihydroindole 失效
标题翻译： ANGIOTENSIN II ANTAGONISTS INCORPORATING替代的吲哚或二氢吲哚
公开(公告)号：US5175164A
公开(公告)日：1992-12-29
申请号：US710413
申请日：1991-06-05
申请人： Scott Bagley , William J. Greenlee , Daljit S. Dhanoa , Arthur A. Patchett
发明人： Scott Bagley , William J. Greenlee , Daljit S. Dhanoa , Arthur A. Patchett
IPC分类号： A61K31/41 , A61K31/505 , A61P9/12 , A61P27/02 , A61P43/00 , C07D401/14 , C07D403/06 , C07D403/14 , C07D471/04 , C07F9/6558
CPC分类号： C07D403/06 , C07D403/14 , C07D471/04
摘要： Substituted heterocycles attached through a methylene bridge to novel substituted indole or dihydroindole derivative of the Formula I are useful as angiotensin II antagonists. ##STR1##

4. 发明申请

US20070191429A1 PPAR ACTIVATORS 审中-公开
标题翻译： PPAR激活剂
公开(公告)号：US20070191429A1
公开(公告)日：2007-08-16
申请号：US11694337
申请日：2007-03-30
申请人： Scott Bagley , Thomas Brandt , Robert Dugger , William Hada , Cheryl Hayward , Zhengyu Liu
发明人： Scott Bagley , Thomas Brandt , Robert Dugger , William Hada , Cheryl Hayward , Zhengyu Liu
IPC分类号： A61K31/454 , A61K31/445 , C07D211/06 , C07D417/02
CPC分类号： C07D211/22 , C07D211/26 , C07D401/06 , C07D405/06 , C07D417/06 , C07D417/14
摘要： PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
摘要翻译： PPARα激活剂，含有这些化合物的药物组合物以及使用这些化合物来提高某些血浆脂质水平，包括高密度脂蛋白胆固醇和降低某些其他血浆脂质水平，如低密度脂蛋白胆固醇和甘油三酸酯，从而治疗由哺乳动物（包括人类）中低密度脂蛋白胆固醇和/或高水平的低密度脂蛋白胆固醇和甘油三酯（如动脉粥样硬化和心血管疾病）而加剧。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式